Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Magrolimab + Mogamulizumab for T-Cell Lymphoma
Recruiting1 awardPhase 1 & 2
Oklahoma City, Oklahoma
This trial is testing magrolimab in combination with mogamulizumab to see if it can help patients with T-cell lymphoma that has come back or does not respond to treatment. Magrolimab and mogamulizumab are monoclonal antibodies that may interfere with the ability of cancer cells to grow and spread.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service